These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8399589)

  • 1. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity.
    Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD
    Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.
    Topley N; Williams JD
    Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045
    [No Abstract]   [Full Text] [Related]  

  • 3. Peritoneal function and peritonitis in patients on peritoneal dialysis.
    Friedlander M
    J Lab Clin Med; 1993 Dec; 122(6):639-40. PubMed ID: 8245682
    [No Abstract]   [Full Text] [Related]  

  • 4. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of peritoneal dialysis on cytokine production by peritoneal cells.
    Topley N; Williams JD
    Blood Purif; 1996; 14(2):188-97. PubMed ID: 8785035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal permeability and encapsulating peritonitis.
    Verger C; Celicout B
    Lancet; 1985 Apr; 1(8435):986-7. PubMed ID: 2859446
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability.
    Zemel D; Krediet RT
    Blood Purif; 1996; 14(2):198-216. PubMed ID: 8785036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of apoptosis by lethal cytokines in human mesothelial cells.
    Catalan MP; Subirá D; Reyero A; Selgas R; Ortiz-Gonzalez A; Egido J; Ortiz A
    Kidney Int; 2003 Jul; 64(1):321-30. PubMed ID: 12787425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell populations present in the nocturnal peritoneal effluent of patients on continuous ambulatory peritoneal dialysis and their relationship with peritoneal function and incidence of peritonitis.
    Fernandez de Castro M; Selgas R; Jimenez C; Auxiliadora Bajo M; Martinez V; Romero JR; de Alvaro F; Vara F
    Perit Dial Int; 1994; 14(3):265-70. PubMed ID: 7948240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing encapsulating peritonitis in children.
    Niaudet P; Berard E; Revillon Y; Lothon M; Broyer M
    Contrib Nephrol; 1987; 57():230-8. PubMed ID: 3677698
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
    Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.
    Szeto CC; Wong TY; Lai KB; Chow KM; Li PK
    Perit Dial Int; 2002; 22(2):265-7. PubMed ID: 11990414
    [No Abstract]   [Full Text] [Related]  

  • 15. Peritoneal membrane failure as a determinant of the CAPD future. An epidemiological, functional and pathological study.
    Huarte-Loza E; Selgas R; Carmona AR; Martinez ME; Muñoz J; Fontan MP; Ortega O; Escuin F; Sicilia LS
    Contrib Nephrol; 1987; 57():219-29. PubMed ID: 3677696
    [No Abstract]   [Full Text] [Related]  

  • 16. The peritoneal membrane in chronic peritoneal dialysis.
    Krediet RT
    Kidney Int; 1999 Jan; 55(1):341-56. PubMed ID: 9893150
    [No Abstract]   [Full Text] [Related]  

  • 17. The peritoneal immune system and continuous ambulatory peritoneal dialysis.
    Rapoport J; Hausmann MJ; Chaimovitz C
    Nephron; 1999; 81(4):373-80. PubMed ID: 10357643
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.
    McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
    Eur J Clin Pharmacol; 1985; 28(2):187-91. PubMed ID: 3987798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
    Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
    Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.